Oregon Cannabis: 769 Stores, 100% Resident Capture, and the Low-Tax Blueprint

Share

Oregon's cannabis market generates ~$925 million annually at $3.33/g flower. A 17% excise rate and open licensing produced the most price-competitive legal market in the country — and complete black market displacement as a result.

Market Overview

Oregon legalized adult-use cannabis under Measure 91 in November 2014. First recreational sales began October 1, 2015 through existing medical dispensaries, with a dedicated retail system launching in 2016. The market is regulated by the Oregon Liquor and Cannabis Commission (OLCC).

Key metrics:

  • 769 dispensaries statewide (active retail licenses, Dec 2025)
  • 2025 annualized revenue: ~$925 million ($848M through November)
  • $77.1 million average monthly revenue (Jan–Nov 2025)
  • $3.33/g flower (November 2025, OLCC median retail pre-tax)
  • 17-20% total tax burden (17% state excise + up to 3% local; no state sales tax)
  • ~100% estimated resident capture at current pricing
  • Licensing moratorium in effect since March 2024

Flower Pricing

Oregon's pricing data comes directly from the OLCC's monthly market data, which tracks both revenue and weight sold by product category — one of the cleaner data sets in the country.

Flower has fallen steadily since the market opened, driven by uncapped cultivation licensing in the early years and relentless competition among 769 retailers. The current $3.33/g pre-tax retail price sits below the black market in every adjacent state. After Oregon's 17–20% tax, out-the-door pricing runs $3.89–4.00/g — cheaper than illicit alternatives, which run $4–5/g in the region.

MarketPre-tax PriceTax BurdenFinal PriceLegal Capture
Michigan$2.96/g~17%~$3.46165%
Colorado$3.18/g15-20%$3.66-3.82104%
Oregon$3.33/g17-20%$3.89-4.00100%
Massachusetts$4.01/g17-20%$4.69-4.81100%
New Mexico$4.04/g~20-21%~$4.80138%
Montana$5.34/g20-23%$6.41-6.57107%
Nevada$5.11/g~27%$6.49100%
Rhode Island$5.67/g20%$6.8039%
California$6.11/g23-40%$7.52-8.5563%
Illinois$6.25/g25-35%$8.1330%
Connecticut$7.69/g26-34%$9.66-10.2820%
New Jersey$8.09/g8-10%$8.8020%
New York$10.61/g20-22%$12.708%
Minnesota$13.54/g22-25%$16.50-16.906%

Oregon's 17% excise rate is the critical variable. The empirical pattern across markets is consistent: total tax burdens below 20% produce capture rates at or above 100%; burdens above 25% produce capture rates below 35%. Illinois runs 25–35% and captures 30%. Oregon runs 17–20% and captures everything.

Tax Structure

  • 17% state cannabis excise tax on retail sales (adult-use and medical)
  • Up to 3% local option tax (varies by jurisdiction)
  • No state sales tax (Oregon has no general sales tax)
  • Combined effective burden: 17–20%

Oregon's tax design is the simplest in the dataset — a single flat retail excise with no tiered rates, no THC-graduated tiers, no wholesale layer. That simplicity keeps compliance costs low and pricing predictable for consumers.

Total Addressable Market

Oregon's adult population is approximately 3.28 million. Applying the empirically validated consumption baseline of 18% participation at 1.0 gram per day:

  • 3.28 million adults 21+
  • 590,400 estimated regular consumers (18%)
  • 215 million grams annual demand (590,400 × 365)

At Oregon's $3.33/g flower price, the resident TAM is approximately $717 million on a flower-equivalent basis. Actual 2025 revenue of ~$925 million exceeds this by roughly 29% — the surplus reflects the revenue premium from concentrates and vapes ($15.40/g average retail), which represent 38% of sales, plus modest cross-border spending from Washington and California residents exploiting Oregon's lower effective price.

The consumption data validates the framework directly. Oregon's OLCC tracks weight sold: November 2025 recorded 24,506 pounds (11.1 million grams) of usable flower. Divided across 590,400 estimated consumers over 30 days, that yields 0.63 g/day of flower — in the middle of the validated 0.5–0.7 g/day range confirmed across seven jurisdictions. Total consumption including concentrates and edibles converted to flower-equivalent lands at approximately 1.0 g/day, consistent with the consumption baseline.

Revenue Trend

Oregon's market has been essentially flat since 2022 — the behavior of a mature market at full capture, not a growing one:

YearTotal RevenueNotes
2020~$1.1BPandemic demand surge
2021~$1.1BPeak
2022~$1.05BSlight decline begins
2023~$975MPrice compression
2024~$940MContinued compression
2025~$925MAnnualized (Jan–Nov)

Revenue has declined roughly 16% from the 2021 peak. This mirrors the Colorado and Nevada pattern: price compression drives revenue down while grams sold hold steady or increase. Oregon is selling more cannabis than ever; it's just worth less per gram than it used to be. The licensing moratorium implemented in March 2024 is a structural response to the same oversupply dynamic.

The oversupply that drove wholesale prices to commodity lows also created a secondary problem with a different cause. Oregon grows significantly more cannabis than its residents can legally consume, and federal law prohibits exporting the surplus to other states. When licensed operators can't move product at any margin, some look for unlicensed channels. Law enforcement operations in rural Southern Oregon — including a single 2022 seizure of 90,000 pounds in Josephine County — are production and export busts, not evidence of a domestic retail black market competing with licensed dispensaries. At $3.89/g on the legal market, there is no price signal that would lead an Oregon consumer to seek out an illegal alternative. The illicit market exists above and behind the legal retail layer, not underneath it.

Product Mix

Oregon's product distribution reflects nine years of consumer preference evolution:

ProductRevenue Share (Nov 2025)
Flower42.3%
Vapes25.9%
Edibles/tinctures14.7%
Concentrates12.1%
Other5.0%

Flower has declined from roughly 70% of revenue in the market's early years to 42% today. The shift to vapes and concentrates is consistent across mature markets and reflects consumer preference for convenience and potency rather than any failure of flower. It also matters for capture rate calculations — flower-only TAM analysis understates the actual market by roughly 35%.

Dispensary Density

At 769 stores for 590,400 estimated consumers, Oregon averages 767 consumers per store — the lowest utilization of any full-capture state in this dataset. For comparison, Nevada achieves full capture at 2,691 consumers per store. The over-licensing problem is real: average annual revenue per Oregon retailer is approximately $1.2 million, below the threshold most operators need to run a viable business.

MarketStoresAdults 21+Per 100KRevenue/StoreLegal Capture
Colorado9004.5M20.0$2.15M104%
Maine1791.4M12.8$2.87M100%
Oregon7693.28M23.4$1.2M100%
Massachusetts4055.6M7.2$4.07M100%
Nevada1032.46M4.2$8.05M100%
New Jersey2707.15M3.8$4.31M20%
Illinois26412.4M2.1$7.42M30%

Oregon's 23.4 dispensaries per 100K adults is the expected result of uncapped licensing — abundant access produces full capture almost by definition. The more instructive comparison is Nevada, which achieved the same 100% capture at 4.2 per 100K through geographic concentration rather than density saturation. Full capture has a floor somewhere between those two points; Oregon's experience tells us more about what over-licensing costs in per-store revenue than it does about what capture requires. At 767 consumers per store and $1.2M average annual revenue, most Oregon retailers are operating at margins that aren't viable long-term. The licensing moratorium is the structural acknowledgment of that.

Home Cultivation

Oregon allows adults 21+ to cultivate up to four plants per household out of public view. The policy has had negligible revenue impact — Oregon's own market data shows consistent revenue growth alongside the home grow right, with cultivation participation estimated at 3–5% of users. At $3.89/g retail with no setup costs or time commitment, legal retail is simply more economical for virtually all consumers. The home grow right serves medical patients and self-sufficiency-motivated users without affecting the commercial market.

What the CHS Literature Missed

The Oregon Health Authority's Cannabis and Your Health page covers immediate effects, pregnancy risks, breastfeeding, youth prevention, safe storage, and driving impairment. CHS does not appear anywhere — not in the health risk disclosures, not in the FAQ, not in the OHA's approved public health statements reviewed by their Scientific Advisory Committee.

Oregon has been selling legal cannabis since 2015. The state oversees an estimated 590,400 regular consumers across 769 licensed dispensaries. If CHS affected 17–33% of daily users as some clinical estimates suggest, Oregon's consumer base would include 53,000–97,000 sufferers — a public health burden that would register prominently in a state health authority's cannabis guidance. The OHA's omission of CHS from its consumer-facing materials is consistent with what population-level data suggests about the syndrome's actual prevalence: a real but rare condition affecting a small subset of susceptible users, not a mass-casualty event hiding in plain sight across a decade of legal sales.

The Bottom Line

Oregon is the proof of concept for the low-tax, open-licensing approach to black market displacement. The 17% excise rate kept legal prices below illicit alternatives from the market's earliest years, full-capture was achieved relatively quickly, and the black market has been functionally eliminated for resident demand.

The cost of that approach is now visible in the revenue data: $1.2 million average per-store revenue and a licensing moratorium because the unlimited-entry model created more retailers than the market can support at commodity prices. Oregon achieved the right outcome — complete displacement — through a model that is now correcting its structural excesses.

The revenue trend confirms where the market sits: post-capture, price-compressing, and approaching a floor. The $925 million market will likely stabilize somewhere in the $850–900 million range as prices find their commodity equilibrium and the store count normalizes through attrition.


This analysis applies the Dan K Reports Cannabis Market Framework. For methodology, assumptions, and the complete state-by-state comparison, see the framework documentation.